Advertisement
Screener

PALISADE BIO, INC. (PALI) Subsidiaries

PALISADE BIO, INC. Subsidiaries

Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (7 lists). Names and jurisdictions are as filed.

  • 2023-03-22: Subsidiary Leading Biosciences, Inc.; Jurisdiction Delaware.
  • 2023-03-22: Subsidiary Suzhou Neuralstem Biopharmaceutical Co., Ltd.; Jurisdiction People’s Republic of China.
  • 2022-03-17: Subsidiary Leading Biosciences, Inc.; Jurisdiction Delaware.
  • 2022-03-17: Subsidiary Suzhou Neuralstem Biopharmaceutical Co., Ltd.; Jurisdiction People’s Republic of China.
Annual report filedSubsidiaryJurisdiction
2023-03-22Leading Biosciences, Inc.Delaware
2023-03-22Suzhou Neuralstem Biopharmaceutical Co., Ltd.People’s Republic of China
2022-03-17Leading Biosciences, Inc.Delaware
2022-03-17Suzhou Neuralstem Biopharmaceutical Co., Ltd.People’s Republic of China
2021-03-221.Suzhou Neuralstem Biopharmaceutical Co., Ltd organized under the laws of the People’s Republic of China.
2021-03-222.Townsgate Acquisition Sub 1, Inc., organized under the laws of the state of Delaware.
2014-03-10Suzhou Neuralstem Biopharmaceutical Co., Ltd organized under the laws of the People’s Republic of China.
2013-03-15Suzhou Neuralstem Biopharmaceutical Co., Ltd organized under
2012-03-30Suzhou Neuralstem Biopharmaceutical Co., Ltd organized under
2011-03-16Suzhou Neuralstem Biopharmaceutical Co. , Ltd organized under the laws of the People’s Republic of China

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Liminatus Pharma, Inc. (LIMN)United States$0.282B
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35